A new clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease. Oxford University Hospitals NHS Foundation Trust is one of the centres where the trial will be conducted, and where patients will be recruited. Research at ... READ MORE
News
Controlling infection essential to tackle global anaemia
A study supported by the NIHR Oxford Biomedical Research Centre has concluded that iron supplements on their own are not enough to efficiently tackle anaemia in places with high infection burdens. In a paper published in The BMJ, Prof Hal Drakesmith from the MRC Human Immunology Unit, based at ... READ MORE
Students go in2science to get invaluable lab experience
Six A-level students have been getting first-hand experience of working in a top research laboratory during their summer holidays. The students, from different schools across Oxfordshire, have been getting valuable work experience at the Oxford Centre for Diabetes, Endocrinology and Metabolism ... READ MORE
First treatment designed specifically to prevent migraine gets European licence
The first ever drug specifically designed to prevent migraines in adults has been approved by the European Medicines Agency (EMA), and the head of the Oxford Headache Centre has said the news represents a new approach in treating the condition. The EMA granted a licence for the use of erenumab, ... READ MORE
Knowing you are pre-diabetic does not usually lead to changes in lifestyle, study finds
Social and cultural factors mean that people who are told they are pre-diabetic are too often unable to make the necessary lifestyle changes to prevent progression to diabetes, according to a study by researchers supported by the NIHR oxford Biomedical Research Centre. The study, ‘How are ... READ MORE
Researchers map leukaemia ‘family trees’ in patients treated with new drug
A team of international researchers, including experts from NIHR Oxford BRC, has for the first time mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains what happens when a patient ... READ MORE
One dose of aspirin doesn’t fit all
About one billion people worldwide take regular aspirin, usually to prevent heart attacks or strokes. Writing in The Lancet, researchers have shown that ‘one-dose-fits-all’ use of aspirin to prevent heart attacks, stroke or cancer, is ineffective or harmful in the majority of people, and that a ... READ MORE
Pregnant women invited to take part in pioneering diabetes prevention research
Pregnant women are being invited by the University of Oxford and the NHS to take part in the world’s first clinical trial to prevent type 1 diabetes in babies and infants. Researchers supported by the NIHR Oxford Biomedical Research Centre want to find out if giving small amounts of insulin to ... READ MORE
Ultrasound and nanomedicine offer new hope for improving effects of cancer drugs
In a breakthrough that allows the more precise targeting of drugs at cancers, a University of Oxford team has used ultrasound and lipid drug carriers to remotely trigger and enhance the delivery of a cancer drug in humans for the first time. The study was conducted by researchers from the ... READ MORE
#OxfordImpact2018
Post by Prof Trish Greenhalgh, NIHR Oxford BRC Theme Lead for Partnerships for Health, Wealth and Innovation The most memorable sentence from this one-day workshop held at Jesus College, Oxford, on 21 June 2018 was from keynote speaker Mark Taylor. Reflecting on his experience as a patient with ... READ MORE
- « Previous Page
- 1
- …
- 58
- 59
- 60
- 61
- 62
- …
- 96
- Next Page »